![]() |
| Osteologix Presents Phase 2 Osteoporosis Data At A Major Eu |
|
RSS FEED
|
Osteologix, Inc. (OTCBB: OLGX), a specialty pharmaceutical company, announced today that data from a Phase II clinical study of NB S101 (strontium malonate) was presented at the European Calcified Tissue Society's 35th Annual Meeting in Barcelona, Spain.
Read more... |
||||||||||||
|
|
|||||||||||||
| Osteologix Presents Phase 2 Osteoporosis Data At A Major Eu |
|
||
|
Site Map
|
Sitemap |
